Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
16
pubmed:dateCreated
1992-9-15
pubmed:abstractText
The alpha-adrenergic agonist oxymetazoline increased Na+,K(+)-ATPase activity of single proximal convoluted tubules dissected from rat kidney. Activation of the enzyme by oxymetazoline was prevented by either the alpha 1-adrenergic antagonist prazosin or the alpha 2-adrenergic antagonist yohimbine and was mimicked by the calcium ionophore A23187. The effect of oxymetazoline on Na+,K(+)-ATPase activity was prevented by a specific peptide inhibitor of calcineurin, as well as by FK 506, an immunosuppressant agent known to inhibit calcineurin; these results indicate that the action of oxymetazoline is mediated via activation of calcineurin (a calcium/calmodulin-dependent protein phosphatase). Activation of the Na+,K(+)-ATPase by either oxymetazoline or A23187 was associated with a greater than 2-fold increase in its affinity for Na+. The results provide a biochemical mechanism by which norepinephrine, released from renal nerve terminals, stimulates Na+ retention.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-1662394, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-1674621, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-1715244, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-1849276, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-1977083, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-1979719, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-2057526, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-2153670, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-2153935, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-2153972, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-2166000, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-2442626, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-2541767, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-2567349, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-2573060, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-2835594, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-2853370, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-3013843, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-6087160, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-6256521, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-6306765, http://linkedlifedata.com/resource/pubmed/commentcorrection/1380157-6316077
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Calcimycin, http://linkedlifedata.com/resource/pubmed/chemical/Calcineurin, http://linkedlifedata.com/resource/pubmed/chemical/Calmodulin-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Oxymetazoline, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Phosphoprotein Phosphatases, http://linkedlifedata.com/resource/pubmed/chemical/Polyenes, http://linkedlifedata.com/resource/pubmed/chemical/Prazosin, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, alpha, http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus, http://linkedlifedata.com/resource/pubmed/chemical/Sodium-Potassium-Exchanging ATPase, http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus, http://linkedlifedata.com/resource/pubmed/chemical/Yohimbine
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
89
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7394-7
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed-meshheading:1380157-Animals, pubmed-meshheading:1380157-Calcimycin, pubmed-meshheading:1380157-Calcineurin, pubmed-meshheading:1380157-Calmodulin-Binding Proteins, pubmed-meshheading:1380157-Kidney Cortex, pubmed-meshheading:1380157-Kidney Tubules, Proximal, pubmed-meshheading:1380157-Kinetics, pubmed-meshheading:1380157-Models, Biological, pubmed-meshheading:1380157-Oxymetazoline, pubmed-meshheading:1380157-Peptides, pubmed-meshheading:1380157-Phosphoprotein Phosphatases, pubmed-meshheading:1380157-Polyenes, pubmed-meshheading:1380157-Prazosin, pubmed-meshheading:1380157-Rats, pubmed-meshheading:1380157-Receptors, Adrenergic, alpha, pubmed-meshheading:1380157-Signal Transduction, pubmed-meshheading:1380157-Sirolimus, pubmed-meshheading:1380157-Sodium-Potassium-Exchanging ATPase, pubmed-meshheading:1380157-Tacrolimus, pubmed-meshheading:1380157-Yohimbine
pubmed:year
1992
pubmed:articleTitle
Calcineurin mediates alpha-adrenergic stimulation of Na+,K(+)-ATPase activity in renal tubule cells.
pubmed:affiliation
Department of Pediatrics, St. Göran's Children's Hospital, Karolinska Institutet, Stockholm, Sweden.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't